🇸🇪 Sweden Country × Condition
dyslipidemias Clinical Trials in Sweden
Active clinical trials for dyslipidemias with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇸🇪 Sweden
Active Trials in Sweden (2)
NCT06797401 Phase 2
Recruiting
Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Enrollment
120 pts
Country
🇸🇪 Sweden
Ribocure Pharmaceuticals AB
View Trial → NCT06019910
Recruiting
Snus and Home Blood Pressure
Enrollment
28 pts
Country
🇸🇪 Sweden
University Hospital, Linkoeping
View Trial → Frequently Asked Questions
How many dyslipidemias clinical trials are active in Sweden?
There are currently 2 active clinical trials for dyslipidemias with sites in Sweden, of which 2 are actively recruiting patients.
How can I join a dyslipidemias clinical trial in Sweden?
To join a dyslipidemias clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are dyslipidemias trials in Sweden?
Active dyslipidemias trials in Sweden span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.